US FDA Oncology Center Wants Trial Datasets Flagged As Remote Or In-Person Assessments

 
• By Sue Sutter

Agency wants to use pandemic-interrupted clinical trials to gauge how decentralized approaches impacted study integrity and to inform prospective use of such designs post-COVID.

Flags red and green
Special flags for 'remote' and 'trial site' assessments in cancer trial datasets will inform the use of decentralized approaches going forward. • Source: Shutterstock

More from Clinical Trials

More from R&D